These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13990036)

  • 1. Intestinal transport of azaserine and DON.
    SPENCER RP; BOW TM; MARKULIS MA
    Biochem Pharmacol; 1963 Jun; 12():599. PubMed ID: 13990036
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytochemical effects of azaserine and DON on ribonucleic acid of Ehrlich ascites tumor cells.
    LINDNER A; LARSEN A
    AMA Arch Pathol; 1958 Apr; 65(4):415-9. PubMed ID: 13520053
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of uric acid biosynthesis in birds by o-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L-norleucine (DON).
    KRAKOFF IH; KARNOFSKY DA
    Am J Physiol; 1958 Oct; 195(1):244-50. PubMed ID: 13583156
    [No Abstract]   [Full Text] [Related]  

  • 4. Azaserine resistance in a plasma-cell neoplasm without change in active transport of the inhibitor.
    ANDERSON EP; JACQUEZ JA
    Cancer Res; 1962 Jan; 22():27-37. PubMed ID: 13861221
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumor effects of azaserine and DON.
    Burchenal JH
    Cancer Treat Rep; 1979 Jun; 63(6):1031-2. PubMed ID: 466642
    [No Abstract]   [Full Text] [Related]  

  • 6. Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity.
    Catane R; Von Hoff DD; Glaubiger DL; Muggia FM
    Cancer Treat Rep; 1979 Jun; 63(6):1033-8. PubMed ID: 380801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inactivation of microbial glutamin-(asparagin-)ase by azaserine and 6-diazo-5-oxo-L-norleucine].
    Lebedeva ZI; Kabanova EA; Berezov TT
    Biull Eksp Biol Med; 1985 Dec; 100(12):696-8. PubMed ID: 4074870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic activity of combinations of 6-chloropurine and azaserine.
    SARTORELLI AC; BOOTH BA
    Cancer Res; 1960 Feb; 20():198-203. PubMed ID: 14441824
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutagenic effect of azaserine in relation to azaserine resistance in Escherichia coli.
    IYER VN; SZYBALSKI W
    Science; 1959 Mar; 129(3352):839-40. PubMed ID: 13635022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal transport of deoxynivalenol across porcine small intestines.
    Halawa A; Dänicke S; Kersten S; Breves G
    Arch Anim Nutr; 2013 Apr; 67(2):134-46. PubMed ID: 23521693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOME FACTORS AFFECTING THE TUMOR-INHIBITORY PROPERTIES OF COMBINATIONS OF AZASERINE AND 6-CHLOROPURINE.
    SARTORELLI AC; BOOTH BA
    Biochem Pharmacol; 1963 Aug; 12():847-53. PubMed ID: 14071542
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzymatic degradation of azaserine.
    JACQUEZ JA; SHERMAN JH
    Cancer Res; 1962 Jan; 22():56-61. PubMed ID: 14450824
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of azaserine on glutamine uptake by rat renal brush-border membranes.
    Hsu BY; Marshall CM; McNamara PD; Segal S
    Biochem J; 1980 Oct; 192(1):119-26. PubMed ID: 6118132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filament formation in E. coli induced by azaserine and other antineoplastic agents.
    MAXWELL RE; NICKEL VS
    Science; 1954 Aug; 120(3111):270-1. PubMed ID: 13186832
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of azaserine on Azotobacter agilis.
    DELHUMEAU-ARRECILLAS G; BURRIS RH
    J Bacteriol; 1959 Nov; 78(5):740-1. PubMed ID: 13815649
    [No Abstract]   [Full Text] [Related]  

  • 16. AZASERINE AND THIOPURINES. I. INHIBITION OF S-180 MOUSE TUMOR AND ANTIBODY SYNTHESIS.
    HANSEN HJ; VANDEVOORDE JP; BENNETT KJ; GILES WG; NADLER SB
    J Lab Clin Med; 1964 May; 63():801-18. PubMed ID: 14158063
    [No Abstract]   [Full Text] [Related]  

  • 17. Action of azaserine on Escherichia coli.
    KAPLAN L; REILLY HC; STOCK CC
    J Bacteriol; 1959 Oct; 78(4):511-9. PubMed ID: 14404400
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitors of tumor growth: N-chloroacetyl-beta-alanine, N-chloroacetylglutamic acid, and azaserine.
    BROWN RW; GRISOLIA S
    J Kans Med Soc; 1960 Mar; 61():157-8. PubMed ID: 13805034
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of optimal medical care with and without azaserine in multiple myeloma.
    HOLLAND JF
    Clin Pharmacol Ther; 1961; 2():22-8. PubMed ID: 13715278
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of ascites tumour growth by the trypanocide, ethidium bromide, in combination with azaserine.
    KANDASWAMY TS; HENDERSON JF
    Nature; 1962 Jul; 195():85. PubMed ID: 14453546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.